Standard Operating Procedure for Monitoring Country-Specific Registration Rule Changes
| Department | Regulatory Affairs |
| SOP No. | RA/2026/638 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 09/04/2026 |
| Effective Date | 09/04/2026 |
| Review Date | 09/04/2028 |
Purpose
This Standard Operating Procedure (SOP) provides a systematic and controlled approach to monitoring changes in country-specific regulations related to product registration. It supports the objective of ensuring that all relevant regulatory requirements are identified, evaluated, and incorporated timely to maintain compliance and enable uninterrupted market access. This SOP establishes the methodology to track regulatory updates, assess their impact, and facilitate appropriate actions to uphold regulatory compliance within the organization’s global regulatory affairs function.
Scope
This SOP applies to all activities involved in the identification, tracking, evaluation, communication, and documentation of country-specific registration rule changes impacting pharmaceutical products, submissions, labeling, and registration dossiers. It encompasses all regulatory affairs personnel responsible for monitoring regulatory environments across all markets where the company’s products are registered or intended for registration. Excluded from this SOP are global regulatory changes not specific to country-level registration rules, and internal procedural amendments unrelated to external regulatory updates.
Responsibilities
The following roles are responsible for executing and supporting this SOP:
- Regulatory Affairs Associates/Officers – Monitor regulatory databases, country authority websites, and other relevant sources to identify registration rule changes.
- Regulatory Intelligence Team – Consolidate updates, perform initial impact assessment, and escalate significant regulatory changes.
- Regulatory Affairs Manager – Review the assessments, coordinate cross-functional impact analysis, and authorize required actions.
- Quality Assurance – Review updated regulatory documents and ensure changes are adequately reflected in quality systems and compliance documentation.
- Document Control – Manage revision and archival of regulatory tracking logs, SOPs, and related documents.
Accountability
The Head of Regulatory Affairs is accountable for the overall implementation, compliance, and periodic review of this SOP. This role ensures timely escalation of critical regulatory changes, oversees effectiveness monitoring, and facilitates continuous improvement to maintain robust regulatory intelligence capabilities.
Procedure
1. Preparation and Prerequisites: All personnel involved must be trained on this SOP and have access to relevant regulatory intelligence platforms, government regulatory authority websites, subscription databases, and internal regulatory tracking tools.
2. Monitoring Regulatory Sources: Regulatory Affairs Associates shall routinely monitor predefined regulatory websites, newsletters, and databases for updates on country-specific registration requirements. This activity shall be documented daily in a Regulatory Monitoring Log.
3. Identification and Recording of Changes: When a potential regulatory change is identified, the details must be recorded immediately in the Regulatory Change Tracking Form, including the nature of change, affected country, sources, publication date, and effective date if available.
4. Initial Assessment: The Regulatory Intelligence Team evaluates the significance of each identified change relative to ongoing product registrations, submissions, or marketing authorizations. They classify changes by impact severity and urgency.
5. Impact Analysis and Cross-Functional Review: For changes with medium to high impact, Regulatory Affairs Manager convenes a cross-functional team involving Quality Assurance, Manufacturing, and other relevant departments to analyze operational and compliance implications.
6. Decision and Action Planning: Based on impact assessment, appropriate actions are determined such as dossier updates, re-submissions, label modifications, or process adjustments. A regulatory action plan is created documenting timelines, responsibilities, and deliverables.
7. Communication and Documentation: All relevant stakeholders are notified of regulatory changes and required actions through official communication channels. Updated documentation is controlled and archived as per document management procedures.
8. Monitoring Compliance and Effectiveness: Follow-up reviews are conducted to confirm implementation of required regulatory changes and ensure compliance. Deviations or delays are reported for corrective action.
9. Record Retention and Closure: All records related to monitoring, assessments, communications, and actions taken are retained in accordance with regulatory and company document retention policies. The Regulatory Change Tracking Form is updated to reflect closure.
10. Review and Update of This SOP: This SOP shall be reviewed biennially or upon significant process or regulatory environment changes to maintain adequacy and compliance.
By following these steps, the organization ensures a proactive, controlled approach to managing and complying with country-specific registration rules, enabling audit readiness and minimizing regulatory risk.
Abbreviations
RA: Regulatory Affairs
QA: Quality Assurance
SOP: Standard Operating Procedure
MA: Marketing Authorization
GMP: Good Manufacturing Practice
Documents
- Regulatory Change Tracking Form (Annexure-1)
- Regulatory Monitoring Log (Annexure-2)
- Regulatory Action Plan Template (Annexure-3)
References
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guidelines
Good Regulatory Practice (GRP) standards
21 CFR Part 314 – Applications for FDA Approval to Market a New Drug
Annex 11 – Computerized Systems (EU GMP)
ISO 9001:2015 Quality Management Systems – Requirements
Company Quality Management System Manuals and Procedures
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Regulatory Change Tracking Form
Purpose: To document identified country-specific registration rule changes, track their assessment, and record actions taken until closure.
| Change ID | REG-CHG-2026-001 |
| Country | Brazil |
| Description of Change | Update to dossier format requirements for local submission |
| Source | ANVISA Official Gazette |
| Date Identified | 05/04/2026 |
| Effective Date | 01/07/2026 |
| Impact Assessment | Medium |
| Responsible Person | Regulatory Intelligence Team |
| Actions Required | Update dossier templates, notify submission teams |
| Status | Open |
| Closure Date | N/A |
Annexure-2: Regulatory Monitoring Log
Purpose: To record daily monitoring activities of regulatory websites and databases for country-specific changes.
| Date | Source | Country | Change Summary | Monitored By |
|---|---|---|---|---|
| 07/04/2026 | Health Canada Website | Canada | Updated labeling requirements for OTC products | RA Associate |
| 08/04/2026 | PMDA Newsletter | Japan | New stability guidelines published | RA Associate |
Annexure-3: Regulatory Action Plan Template
Purpose: To document planned actions, timelines, responsibilities, and status updates for implementing regulatory changes resulting from country-specific rule updates.
| Action Item | Description | Responsible Department | Due Date | Status |
|---|---|---|---|---|
| Update Dossier Format | Revise dossier templates as per new ANVISA format requirements | Regulatory Affairs | 15/05/2026 | In Progress |
| Staff Training | Conduct training session on updated submission requirements | Quality Assurance | 20/05/2026 | Planned |
| Notify Submission Teams | Communicate change impact and new timelines | Regulatory Intelligence Team | 10/05/2026 | Completed |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 09/04/2026 | 1.0 | Initial issue | New SOP creation |